Completed PHASE4 INTERVENTIONAL 3-arm NCT01074892

A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia (Mirena)

A Multicenter Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia

Sponsor: Helse Nord

Interventions Mirena (levonorgestrel) Provera (medroxyprogesterone) Provera (medroxyprogesterone/progestin)

Updated 6 times since 2017 Last updated: Apr 4, 2019 Started: May 31, 2005 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Endometrial Hyperplasia, this trial is completed. The trial is conducted by Helse Nord and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
May 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jun 2018 — May 2019 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Helse Nord
Norwegian Cancer Society
University Hospital of North Norway

Data source: University Hospital of North Norway

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tromsø, Norway